Hotgen's invested company has obtained domestic Class III medical device registration certificate
Hotgen's affiliated company Hangzhou Aorui Biotechnology Co., Ltd. has obtained the domestic Class III medical device registration certificate. The product is a gene methylation detection kit, suitable for the in vitro qualitative detection of methylation of multiple genes in human plasma, primarily used for assisting in the diagnosis of suspected primary liver cancer
According to the Zhitong Finance APP, Hotgen (688068.SH) announced that its important equity investee, Hangzhou Aorui Biotechnology Co., Ltd. (referred to as "Aorui Biotechnology"), recently obtained the domestic Class III medical device registration certificate. Product name: TSPYL5, RASSF1A, DAB2IP, OTX1, PTPN18, HIST1H3G gene methylation detection kit (PCR fluorescence probe method), which is used for the qualitative detection of methylated TSPYL5, RASSF1A, DAB2IP, OTX1, PTPN18, HIST1H3G genes in human plasma. The product is suitable for clinical auxiliary diagnosis of suspected primary liver cancer
